SMTL ID : 7k03.1

Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to ATR kinase inhibitor AZD6738

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x VJM: 4-(4-{1-[(R)-amino(hydroxy)methyl-lambda~4~-sulfanyl]cyclopropyl}-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl)-1H-pyrrolo[2,3-b]pyridine(Non-covalent)

VJM.1: 13 residues within 4Å: Chain A: W.156, P.157, F.158, H.160, P.161, V.162, N.163, F.166, V.167, Y.170, Y.212, N.213, Y.219 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:W.156, A:V.162, A:F.166, A:V.167, A:Y.212 Hydrogen bonds: A:N.163, A:N.213 Water bridges: A:P.161, A:N.163, A:Y.170 pi-Stacking: A:W.156

4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 8 residues within 4Å: Chain A: P.34, F.35, V.39, Y.47, S.86, Y.89, N.90, L.96 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.90 Water bridges: A:Y.47 EDO.3: 5 residues within 4Å: Chain A: R.53, P.54, M.55, H.78, L.81 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.53, A:R.53, A:P.54 EDO.4: 5 residues within 4Å: Chain A: K.191, Y.192, S.197, D.200, D.201 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.191, A:D.200, A:D.201 EDO.5: 8 residues within 4Å: Chain A: M.150, A.151, V.152, P.153, D.154, S.155, W.156, H.159 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:V.152, A:D.154, A:S.155, A:W.156 Water bridges: A:D.154, A:D.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Karim, R.M. et al., Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain. J.Med.Chem. (2022)

Release Date

2021-09-22

Peptides

Transcription initiation factor TFIID subunit 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Transcription initiation factor TFIID subunit 1

Related Entries With Identical Sequence